Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Roubtsova
Observed name:
Roubtsova, Anna.
Institutions:
Montreal Clinical Research Institute,
Université de Montréal
Observed institutions:
Institut universitaire de cardiologie et de pneumologie de Québec,
Montreal Clinical Research Institute,
Université Laval,
Université de Montréal
ORCID:
0009-0005-5475-8006
Observed ORCID:
0009-0005-5475-8006
OpenAlex ID:
A5007183359
Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte‐specific low‐density lipoprotein receptor degradation and critical role in mouse liver regeneration†
2008
·
Ahmed Zaid
, Anna Roubtsova
, et al.
·
Hepatology
·
421
PDF
Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue
2011
·
Anna Roubtsova
, Mercedes Nancy Munkonda
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
257
PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice
2015
·
Anna Roubtsova
, Ann Chamberland
, et al.
·
Journal of Lipid Research
·
64
PDF
Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other
2015
·
Chutikarn Butkinaree
, Maryssa Canuel
, et al.
·
Journal of Biological Chemistry
·
54
PDF
Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia
2015
·
Zuhier Awan
, Maxime Denis
, et al.
·
Angiology
·
54
Substantial PCSK9 inactivation in β-cells does not modify glucose homeostasis or insulin secretion in mice
2021
·
Marie-Line Peyot
, Anna Roubtsova
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
·
41
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin
2021
·
Delia Susan-Resiga
, Emmanuelle Girard
, et al.
·
Journal of Biological Chemistry
·
36
PDF
Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice
2020
·
Damien Garçon
, François Moreau
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
28
PDF
PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease
2023
·
Vatsal Sachan
, Maïlys Le Dévéhat
, et al.
·
Metabolism
·
24
PDF
PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol
2022
·
Anna Roubtsova
, Damien Garçon
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
·
24
Proprotein convertase 7 (PCSK7) reduces apoA‐V levels
2020
·
Yahya Ashraf
, Stéphanie Duval
, et al.
·
FEBS Journal
·
20
A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice
2018
·
Rachid Essalmani
, Elodie Weider
, et al.
·
Biological Chemistry
·
16
PCSK9 is not secreted from mature differentiated intestinal cells
2021
·
François Moreau
, Aurélie Thédrez
, et al.
·
Journal of Lipid Research
·
10
PDF
Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9
2023
·
Anna Roubtsova
, Corey A. Scipione
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
·
9
Blockade of colon cancer metastasis via single and double silencing of PCSK7 / PCSK9 : enhanced T cells cytotoxicity in mouse and human
2025
·
Chloé Porcheron
, Mailys Le Devehat
, et al.
·
Journal for ImmunoTherapy of Cancer
·
6
GDF10 is a negative regulator of vascular calcification
2024
·
Khrystyna Platko
, Gabriel Gyulay
, et al.
·
Journal of Biological Chemistry
·
6
PDF
The Proprotein Convertase 7 Regulates Triglyceride Levels via Enhanced ApoA5 Degradation
2018
·
Yahya Ashraf
, Vatsal Sachan
, et al.
·
Atherosclerosis Supplements
·
1
LDLR Activity and Subcellular Distribution is Sensitive to Estrogen in Mice Lacking PCSK9
2018
·
Anna Roubtsova
, Marlys L. Koschinsky
, et al.
·
Atherosclerosis Supplements
·
1
Corrigendum to “Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights” [J Clin Lipidol (2026) S1933-2874(26)00045-0, ahead of print]
2026
·
Rachid Essalmani
, Alexandra Evagelidis
, et al.
·
Journal of clinical lipidology
PDF
Identification of a novel apoB variant in a family exhibiting hypocholesterolemia: Mechanistic insights
2026
·
Rachid Essalamani
, Alexandra Evagelidis
, et al.
·
Journal of clinical lipidology
PDF
Corrigendum to “PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease” [Metabolism Volume 150, January 2024, 155736, PMID: 7967646]
2024
·
Vatsal Sachan
, Maïlys LeDévéhat
, et al.
·
Metabolism
Corrigendum: PCSK9 is not secreted from mature differentiated intestinal cells
2022
·
François Moreau
, Aurélie Thédrez
, et al.
·
Journal of Lipid Research
PDF
Abstract 366: Inhibition of Interleukin-1ß by a Monoclonal Antibody Therapy Reduces Vascular Calcification in Ldlr-/- Mice
2014
·
Zuhier Awan
, Maxime Denis
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
Partial hepatectomy and liver regeneration in PCSK9 knockout mice
2008
·
Roubtsova, Anna.
Abstract 261: Liver-specific Pcsk9 Knockout And Transgenic Mice
2007
·
Ahmed Zaid
, Anna Roubtsova
, et al.
·
Circulation
Show more works
View as search
Works count:
26
Citation count:
1,132
H-index:
12
I10-index:
13
Year
Topic
Type